Cite
HARVARD Citation
Halperin, S. et al. (2019). Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults. Journal of infectious diseases. pp. 1127-1135. [Online].